TIGIT and neoplasm: Consistent with our previous experiments, scRNA-seq analysis of tumour CD8+ T cells showed that treatment with anti-PD-L1 + anti-TIGIT antibodies drove reduced expression of genes associated with exhaustion and increased expression of a memory-like gene program relative to single-agent treatment (Fig. 6a and Extended Data Fig. 9c,d).